Terumo Corp. (OTCMKTS:TRUMY) Short Interest Up 80.3% in July

Posted by on Aug 1st, 2026

Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 85,412 shares, a growth of 80.3% from the June 30th total of 47,370 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 287,234 shares, the short-interest ratio is presently 0.3 days.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the company. Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday. Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, Terumo currently has a consensus rating of “Buy”.

Get Our Latest Stock Report on TRUMY

Terumo Stock Down 4.0%

Shares of OTCMKTS:TRUMY traded down $0.61 during trading on Friday, hitting $14.53. The stock had a trading volume of 62,421 shares, compared to its average volume of 133,298. Terumo has a 12 month low of $12.08 and a 12 month high of $19.60. The company has a market capitalization of $21.43 billion, a PE ratio of 23.82 and a beta of 0.68. The firm’s fifty day moving average is $14.01 and its 200 day moving average is $13.54. The company has a quick ratio of 0.97, a current ratio of 1.59 and a debt-to-equity ratio of 0.06.

Terumo (OTCMKTS:TRUMY – Get Free Report) last issued its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. Analysts anticipate that Terumo will post 0.7 EPS for the current fiscal year.

Terumo Company Profile

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

Read More

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.